Med-X is preparing for a possible NASDAQ listing (ticker: MXRX). But the real opportunity is now – before the platform fully scales.
Some companies build products. Others build platforms.
Med-X is doing both.
Beyond Nature-Cide, the company has built a multi-vertical ecosystem including Thermal-Aid and Malibu Brands, supported by retail infrastructure across Amazon, Walmart, and Kroger.
This creates a distribution backbone where new products can scale quickly.
The global wellness market now exceeds $2 trillion, and demand for natural solutions continues to accelerate.
NASDAQ Ticker: MXRX Reserved! The Real Opportunity to Become a Shareholder Is Now!
With $6.4M in sales and expansion into 41 markets, Med-X is building something bigger than a single product.
Simpler. Safer. More Effective Pesticides.
Become a Med-X shareholder at $4 per share before their NASDAQ plans unfold.
Disclosures
This is a paid advertisement for Med-X's Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com
0 Response to "Invest Before Med-X Planned Nasdaq Debut"
Post a Comment